56 results about "Sodium citrate dihydrate" patented technology

A cold fusion concrete formulation including a mixture of water, silicon based mineral aggregates acting as a filler material; sodium or potassium metasilicate / pentahydrate acting as an activator; waste from steel production including Granulated Ground Blast Slag acting as a cementitious ingredient; high calcium or low calcium waste from coal combustion (fly ash or bottom ash) acting as a cementitious ingredient; sodium tetraborate, sodium citrate dihydrate, citric acid, or boric acid acting as set-time retarders; strengthening agents including calcium, potassium, magnesium, sodium, or aluminium hydroxides; attapulgite, kaolin, red, or other fine grained, high alumino silicate containing clay, for increasing the silicon and alumino-silicate concentration and associated strength; a protein or synthetic protein material to form a weak covalent bond with the hydroxides and silicates, for the purpose of maintaining a consistent volume during the curing process; and a pollinated fern oil to reduce water content of the mixture and decrease viscosity.

A cold fusion concrete formulation including a mixture of water, silicon based mineral aggregates acting as a filler material; sodium or potassium metasilicate / pentahydrate acting as an activator; waste from steel production including Granulated Ground Blast Slag acting as a cementitious ingredient; high calcium or low calcium waste from coal combustion (fly ash or bottom ash) acting as a cementitious ingredient; sodium tetraborate, sodium citrate dihydrate, citric acid, or boric acid acting as set-time retarders; strengthening agents including including calcium, potassium, magnesium, sodium,or aluminum hydroxides; attapulgite, kaolin, red, or other fine grained, high alumino silicate containing clay, for increasing the silicon and alumino-silicate concentration and associated strength; aprotein or synthetic protein material to form a weak covalent bond with the hydroxides and silicates, for the purpose of maintaining a consistent volume during the curing process; and a pollinated fern oil to reduce water content of the mixture and decrease viscosity.

Suspensions of pump inhibitors (PPIs) are disclosed. The suspension may include a PPI, a copolymer of ethylene oxide and propylene oxide; simethicone emulsion; Sodium Bicarbonate; and Sodium Citrate, USP (Dihydrate). The suspensions have desirable viscosities and enhanced stability.

The invention provides a high-load platinum and nickel ordered intermetallic compound. The high-load platinum and nickel ordered intermetallic compound takes three-dimensional porous carbon gel as a carrier, and is prepared by a method comprising the following steps: evenly mixing graphene oxide-containing carbon carrier precursor dispersion liquid, a metal precursor solution containing a Pt precursor and an Ni precursor, a reducing agent and sodium citrate dehydrate; then, carrying out a hydrothermal reaction to generate high-load platinum and nickel disordered alloy evenly loaded in carbon gel; after that, carrying out heat treatment under the reducing atmosphere to form the high-load platinum and nickel ordered intermetallic compound evenly loaded in the carbon gel. Compared with the traditional high-load Pt / C catalyst, the catalyst provided by the invention relatively reduces the consumption of precious metal Pt; the activity of the catalyst is improved by using an intermetallic synergistic effect, the stability of the catalyst is improved by using high dispersion of ordered metal nanoparticles, and the high dispersion characteristic of the catalyst is still maintained after ordered heat treatment is carried out on the catalyst. The invention also discloses the preparation method of the high-load platinum and nickel ordered intermetallic compound. The invention also discloses use of the high-load platinum and nickel ordered intermetallic compound.

The invention belongs to the field of pharmaceutical preparation, and particularly relates to stable fasudil hydrochloride injection and a preparation method thereof. The fasudil hydrochloride injection comprises fasudil hydrochloride, stabilizers, anhydrous citric acid, sodium citrate dihydrate, sodium chloride and water for injection, wherein the stabilizers comprise N-carboxymethyl chitosan and reduced glutathione according to the mass ratio of 1:(0.05-0.35). The preparation method includes the steps: dissolving components in the formula by the water for injection after pyrogen removal; adjusting pH (potential of hydrogen); adding medicinal carbon for stirring adsorption to further remove pyrogen and perform discoloration; performing filtration and decarburization; performing filtration, sterilization, sub-package, potting and sterilization to obtain the fasudil hydrochloride injection. The fasudil hydrochloride injection has fine light stability and simple in formula, insoluble particles are effectively suppressed, the preparation process is easily operated, and industrialization is facilitated.